Physician profile
Steven C Burns
NPI 1437154549
$526.10
in general payments reported to CMS, 2019-2025
18 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.19 · 2020: $33.06 · 2021: $12.30 · 2022: $172 · 2023: $42.89 · 2024: $117 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $125.86 | 2022 | |
| Boston Scientific Corporation | $44.73 | 2020-2025 | Watchman Access System |
| Mylan Specialty L.P. | $39.87 | 2024 | Yupelri |
| Novo Nordisk INC | $37.04 | 2020-2025 | |
| Eisai INC. | $35.89 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $29.19 | 2019-2025 | Fasenra |
| Actelion Pharmaceuticals US, INC. | $27.19 | 2024 | Uptravi, Opsumit |
| Abbvie INC. | $25.30 | 2021-2023 | Qulipta |
| Sumitomo Pharma America, INC. | $21.40 | 2025 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $19.94 | 2023 | Gvoke Hypopen |
| Exact Sciences Corporation | $18.62 | 2024 | Cologuard Collection Kit |
| Viatris Specialty LLC | $18.02 | 2025 | Yupelri |
| Amgen INC. | $17.28 | 2024 | Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $14.89 | 2022 | |
| Merck Sharp & Dohme LLC | $14.59 | 2025 | Capvaxive, Gardasil 9 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.72 | 2024 | |
| Lucid Diagnostics INC. | $12.62 | 2022 | |
| Corium, LLC | $9.95 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.